1 Min Read
Feb 16 (Reuters) - Glaukos Corp -
* Glaukos completes patient enrollment in pivotal phase of U.S. IDE clinical trial for iStent supra Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.